SRPT Q1 2020 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$114M+30.6% YoY

Gross Profit

$101M88.9% margin

Operating Income

-$118M-103.8% margin

Net Income

-$17M-15.4% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+13.5%

Cash Flow

Operating Cash Flow

$628M

Free Cash Flow

$619M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$1.8B

Stockholders' Equity

$1.1B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$114M	$87M	+30.6%
Gross Profit	$101M	$75M	+34.8%
Operating Income	-$118M	-$76M	-54.5%
Net Income	-$17M	-$77M	+77.2%